Oropharyngeal Cancer News and Research

RSS

Male virgins still at risk for acquiring HPV, study finds

Men who have never engaged in sexual intercourse are still at risk for acquiring HPV, according to a study published recently in the Journal of Infectious Diseases by researchers at The University of Texas Health Science Center at Houston School of Public Health.

13 Dec 2017

HPV-related oropharyngeal cancer risk remains generally low, study suggests

The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these cancers.

20 Oct 2017

Blood test for HPV could help identify cancer patients suitable for lower treatment doses

A blood test for the human papillomavirus, or HPV, may help researchers forecast whether patients with throat cancer linked to the sexually transmitted virus will respond to treatment, according to preliminary findings from the University of North Carolina Lineberger Comprehensive Cancer Center.

4 Oct 2017

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy

The American Society for Radiation Oncology today issued a new clinical guideline for the management of oropharyngeal cancer.

17 Apr 2017

New antibody test can detect person’s risk for developing HPV-related cancer of the oropharynx

Cancer of the oropharynx has become increasingly common: In the United States alone, the number of newly diagnosed cases has tripled over the past three decades. About 70 percent of these tumors are caused by infection with human papillomavirus (HPV) type 16.

3 Apr 2017

Epigenetic modification may be cause of adult throat cancers linked to alcohol, tobacco use

A team of researchers at the Research Institute of the McGill University Health Centre has found an epigenetic modification that might be the cause of 15% of adult cancers of the throat linked to alcohol and tobacco use.

12 Jan 2017

Study suggests potential blood-based marker to predict oropharyngeal cancer recurrence

A new study suggests the possibility of predicting at its earliest stages when a type of head and neck cancer will come back.

16 Dec 2016

Genes that control immune system play key role in predisposition to HPV-related tumors

A number of genetic variants associated with susceptibility to oral cavity and pharyngeal cancer have been described in an international study published in the journal Nature Genetics.

16 Dec 2016

Mount Sinai introduces first-ever Coursera course on HPV-associated oral and throat cancer

Mount Sinai's Departments of Academic Informatics and Technology and Otolaryngology - Head and Neck Surgery, in conjunction with the Office of Continuing Medical Education at the Icahn School of Medicine at Mount Sinai, have launched the first-ever Coursera course on HPV-associated oral and throat cancer.

7 Dec 2016

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Radiation therapy is the main treatment modality in the management of head and neck cancer.

4 Oct 2016

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another.

28 Sep 2016

TransOral Robotic Surgery may provide good outcomes, survival for oropharyngeal cancer patients

A new study from researchers at Henry Ford Hospital finds an incisionless robotic surgery - done alone or in conjunction with chemotherapy or radiation - may offer oropharyngeal cancer patients good outcomes and survival, without significant pain and disfigurement.

16 Sep 2016

Post-treatment imaging can help detect recurrences of HPV-positive oropharyngeal cancer

For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.

19 Feb 2016

Scientists identify potential marker for recurring HPV-positive oropharyngeal cancer

A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at The Johns Hopkins University.

7 Feb 2016

Beta- and gamma-HPVs associated with development of head and neck cancers, finds Einstein study

Researchers at Albert Einstein College of Medicine have found that when human papillomavirus (HPV)-16 is detected in peoples' mouths, they are 22 times more likely than those without HPV-16 to develop a type of head and neck cancer.

22 Jan 2016

Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

A large population-based study has confirmed the association between the presence of human papillomavirus DNA in oropharyngeal squamous cell cancer and improved patient survival.

27 Nov 2015

FDA awards research grants to boost product development for patients with rare diseases

The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which affect the lives of nearly 30 million Americans.

11 Oct 2015

Breakthrough research to be presented at AAO-HNSF 2015 Annual Meeting & OTO EXPO

Research to be presented tomorrow at the 2015 Annual Meeting & OTO EXPOSM of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF) spans across the otolaryngology specialty.

29 Sep 2015

Radical surgery associated with overall survival benefits among patients with advanced throat cancer

Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer Congress today (Saturday).

26 Sep 2015

Patients with HPV traces post-treatment more likely to have oropharyngeal cancer recurrence

Oropharyngeal cancer patients who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva following cancer treatment are at an increased risk for recurrence, a study led by researchers at the Johns Hopkins Bloomberg School of Public Health has found.

31 Jul 2015